Fidia Spa (IT:FDA) has released an update.
Fidia S.p.A., a leader in numerical control technology, has successfully completed its restructuring plan, as confirmed by the Court of Ivrea. This milestone allows Fidia to enter a new phase of growth with strong support from investors, positioning the company for a successful 2025. The company’s focus on new product development and increasing order recovery signals a promising alignment with its updated industrial plan.
For further insights into IT:FDA stock, check out TipRanks’ Stock Analysis page.
